Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79.1Revenue (TTM) $M29.5Net Margin (%)-128.8Altman Z-Score-6.4
Enterprise Value $M148EPS (TTM) $-0.8Operating Margin %-109.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-128.6Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio6.5Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %0.5Current Ratio6.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-55.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-160.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M64.9ROIC % (ttm)-112.2Gross Margin Increase y-yY

Gurus Latest Trades with ALIM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ALIM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ALIM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Roberts Calvin W.Director 2016-12-12Sell50,000$1.119.91view
EISWIRTH RICHARD S JRPresident and CFO 2016-09-15Sell51,471$1.51-19.21view
BAVP, L.P.10% Owner 2016-04-21Sell478,673$2.59-52.9view
EISWIRTH RICHARD S JRCOO and CFO 2015-12-16Sell46,669$2.31-47.19view
Flynn James E 2015-12-08Buy272,249$3.01-59.47view
Flynn James E 2015-12-03Buy243,252$3-59.33view
Flynn James E 2015-11-06Buy73,250$2.98-59.06view
Flynn James E 2015-10-30Buy16,542$3-59.33view
Flynn James E 2015-10-28Buy59,342$3-59.33view
Flynn James E 2015-10-26Buy60,364$3-59.33view

Quarterly/Annual Reports about ALIM:

    News about ALIM:

    Articles On GuruFocus.com
    Alimera Sciences Inc. (ALIM) President and CEO C. Daniel Myers sells 45,523 Shares Mar 16 2011 
    The Most Speculative Stocks on the Market: Harbinger, Kaching Kaching, Alimera Sciences, Star Scient Jul 29 2010 

    More From Other Websites
    ETFs with exposure to Alimera Sciences, Inc. : January 11, 2017 Jan 11 2017
    Is Alimera Sciences Inc (ALIM) A Good Stock To Buy? Dec 18 2016
    ETFs with exposure to Alimera Sciences, Inc. : December 16, 2016 Dec 16 2016
    ETFs with exposure to Alimera Sciences, Inc. : December 6, 2016 Dec 06 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Nov 16 2016
    ETFs with exposure to Alimera Sciences, Inc. : November 14, 2016 Nov 14 2016
    ALIMERA SCIENCES INC Financials Nov 11 2016
    ALIMERA SCIENCES INC Files SEC form 10-Q, Quarterly Report Nov 04 2016
    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016 Nov 04 2016
    Edited Transcript of ALIM earnings conference call or presentation 3-Nov-16 2:00pm GMT Nov 03 2016
    ETF’s with exposure to Alimera Sciences, Inc. : November 3, 2016 Nov 03 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition Nov 03 2016
    Alimera Sciences Announces Third Quarter 2016 Financial Results and Provides Business Update Nov 02 2016
    Alimera Sciences Announces Third Quarter 2016 Financial Results and Provides Business Update Nov 02 2016
    Q3 2016 Alimera Sciences Inc Earnings Release - After Market Close Nov 02 2016
    Alimera Sciences Begins Selling ILUVIEN® in the Middle East Oct 26 2016
    Alimera Sciences Begins Selling ILUVIEN® in the Middle East Oct 26 2016
    Alimera Sciences to Report Third Quarter 2016 Financial Results on November 2, 2016 Oct 25 2016
    Alimera Sciences to Report Third Quarter 2016 Financial Results on November 2, 2016 Oct 25 2016
    ALIMERA SCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Oct 20 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)